Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are two human autosomal dominant skeletal dysplasias characterized by variable short stature, joint laxity and early-onset degenerative joint disease. Both disorders can result from mutations in the gene for cartilage oligomeric matrix protein (COMP), an extracellular matrix glycoprotein. About one-third of PSACH cases result from heterozygosity for deletion of one codon within a very short triplet repeat, (GAC) 5 , which encodes five consecutive aspartic acid residues within the calmodulin-like region of the COMP protein. We have identified two expansion mutations in this repeat: an MED patient carrying a (GAC) 6 allele and a PSACH patient carrying a (GAC) 7 allele. These are among the shortest disease-causing triplet repeat expansion mutations described thus far, and are the first identified in a GAC repeat. A unique feature of this sequence is that expansion as well as shortening of the repeat can cause the same disease. In cartilage, both patients have rough endoplasmic reticulum inclusions in chondrocytes. The inclusions are also present in tendon tissue and can be reproduced in cultured tendon cells, suggesting that the pathophysiology of disease is similar in both cartilage and tendon.
INTRODUCTION
Cartilage oligomeric matrix protein (COMP) is a pentameric extracellular matrix glycoprotein expressed predominantly in cartilage (1, 2) , but also expressed in tendon (3) (4) (5) (6) , ligament (5, 6) and synovium (7, 8) . It is part of the thrombospondin family of proteins (9) and is also known as thrombospondin-5. Mutations in COMP are responsible for two human autosomal dominant skeletal dysplasias, pseudoachondroplasia (PSACH; OMIM 177170) and multiple epiphyseal dysplasia (MED; OMIM 132400) (10, 11) . PSACH appears to result exclusively from COMP mutations (10-13; D. Cohn and L.M. King, unpublished data), while MED can also result from mutations in the COL9A2 gene of type IX collagen (14, 15) and in at least one additional gene (16) .
PSACH and MED, originally described as distinct disorders, are now recognized as part of a disease spectrum (17) . PSACH is at the severe end of the spectrum and is characterized by short-limb dwarfism with abnormalities of the metaphyses and epiphyses, and a characteristic anterior beaking of the vertebral bodies. The patients also have joint laxity, in particular of the hands and knees. MED is less severe, with generalized abnormalities of the epiphyses, a usually normal spine and mild short stature. In both diseases, early-onset osteoarthrosis, especially in weightbearing joints, is a major complication. Both PSACH and MED can vary in severity, and there is some overlap between the severe cases of MED and the milder cases of PSACH (12) .
Electron microscopy of cartilage from PSACH and MED patients revealed inclusions in the rough endoplasmic reticulum (RER) of chondrocytes (18) (19) (20) . These intracellular inclusions have been shown to contain COMP (5, 6) , as well as other extracellular matrix components including type IX collagen (5,6), aggrecan and possibly link protein (19, 20) .
The COMP monomer is a modular protein composed of an N-terminal coiled-coil domain responsible for the assembly of the pentamer, four epidermal growth factor (EGF)-like repeats, eight calmodulin-like repeats and a globular C-terminal domain (9, (21) (22) (23) . With the exception of one PSACH and one MED mutation in the C-terminal domain (12) , all identified COMP mutations were located in the calmodulin-like domain of the protein and were postulated to affect calcium binding (5, (10) (11) (12) (24) (25) (26) (27) . Approximately one-third of PSACH patients have the same mutation, an in-frame deletion of one of five consecutive GAC codons for the aspartic acid residues at positions 469-473 of the protein (11, 12, 27) .
We have identified two novel mutations in this very short tandem repeat: expansion by one GAC codon in a patient with MED, and expansion by two GAC codons in a PSACH patient. Cartilage and tendon from both patients displayed retention of material in the RER, suggesting that the tissue-specific pathology of the COMP disorders occurs by similar mechanisms in the two tissues.
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RESULTS

Identification of a novel type of mutation in PSACH and MED
We studied two cases, a sporadic patient with PSACH and a family with MED. The pedigree of the MED family is shown in Figure 1 . COMP cDNA was synthesized from RNA isolated from cultured chondrocytes established from cartilage of each patient, and a 797 bp fragment containing the region of the gene encoding the calmodulin-like domain was amplified. Sequence analysis of clones containing the amplified fragment revealed a mutation at the same location for both patients (Fig. 2) . Both mutations resulted in in-frame expansions within the stretch of five consecutive GAC codons at nucleotides 1430-1444. The MED patient was heterozygous for expansion by one codon, increasing the number of GAC codons to six, while the PSACH patient was heterozygous for expansion by two codons, resulting in seven consecutive GAC codons. These expansions predicted COMP proteins with six and seven aspartic acid residues rather than the normal five at positions 469-473 of the protein.
To confirm this result, we amplified a genomic DNA fragment containing the mutations and analyzed the products by electrophoresis on denaturing gels. In a control individual, the PCR product appeared as a single fragment of the expected size. In the MED and PSACH patients, the PCR product contained two species, one of the normal size, and the other three or six base pairs longer, respectively (Fig. 2) , compatible with heterozygosity for the mutation.
The PSACH patient was sporadic in her family, and parental DNA samples were unavailable. In the MED family, the phenotype appeared as a sporadic case and was then inherited in an apparent autosomal dominant fashion in the subsequent generation. By analysis of an amplified genomic DNA fragment containing the mutation on non-denaturing gels, which identified a unique heteroduplex, the mutation appeared coincident with the phenotype in the proband and then segregated with the disease without exception in the subsequent generation (data not shown).
Cell pathology
We obtained tendon tissue as well as cartilage from both patients. Electron microscopy revealed that the chondrocytes of each patient showed the RER inclusions characteristic of PSACH and MED. Chondrocytes in the PSACH patient tissue had the typical lamellar inclusions (Fig. 3) , as well as inclusions containing material in a less organized state (data not shown). The chondrocytes of the MED patient contained granular inclusions of a smaller size than was seen in the PSACH patient cartilage (Fig. 3) .
While it was known that tendon cells synthesize COMP (3-6), the cellular phenotype of tendon cells in patients with COMP mutations has not been described. In tendon from both patients, electron microscopy revealed granular inclusions in the RER (Fig. 3) . We cultured tendon cells from the MED patient, as well as from a fetal control. When kept in culture at confluence for 5 weeks, the tendon cells from the MED patient showed RER inclusions similar to those observed in tendon tissue in vivo (Fig. 3) . Such inclusions were not observed in control cultured tendon cells (data not shown).
DISCUSSION
PSACH and MED are two allelic autosomal dominant skeletal dysplasias caused by heterozygosity for mutations in the COMP gene (10, 11) . One-third of the PSACH patients carry a deletion of one codon in a short GAC repeat which encodes aspartic acid residues 469-473 in the calmodulin-like domain of COMP (11, 12, 27) . We have characterized two new mutations involving the expansion of this stretch to six and seven GAC repeats. The expansions led to two diseases of very different severity: heterozygosity for the (GAC) 6 allele resulted in the milder MED phenotype, while heterozygosity for the (GAC) 7 allele produced a typical PSACH phenotype. Thus both expansion and contraction of the repeat unit can produce PSACH, demonstrating that there are stringent structural requirements governing the function of the calmodulin-like region of COMP.
The calmodulin-like domain of COMP is composed of eight repeats of the consensus sequence NX(D)QXDXDXDGXGD-AC(D)XDXDXDX 8 DNCPX 3 which, by analogy with calmodulin and with other members of the thrombospondin family of proteins, constitute calcium-binding pockets (5, 24) . In the seventh calmodulin-like repeat, the underlined DXDXD sequence is the stretch of five aspartic acids expanded by the identified mutations. In addition to these, the common PSACH deletion and a point mutation (D472Y), which affects the fourth aspartic acid of the stretch, also produce PSACH (11) . Cooperative binding of calcium makes an integral contribution to the overall structure of the calmodulin-like domain of COMP. We hypothesize that the mutations identified in this region disrupt calcium binding by two distinct mechanisms; directly altering charge-charge interactions as in the case of the D472Y substitution, or dramatically altering the structure of the calcium-binding pocket by deletion of one or expansion by two aspartic acid residues. Both mechanisms have similar protein structural consequences and produce the severe PSACH phenotype. We speculate that expansion of the calciumbinding pocket by a single aspartate probably partially preserves both the structure of the pocket and its ability to bind calcium, modulating the phenotypic effect. To test this hypothesis and understand accurately how mutations in this region produce their phenotypic effect, it will be important to resolve the threedimensional structure of the calmodulin-like domain of COMP, gaining an understanding of how the structure of this particular pocket adapts to stretches of four, five, six or seven aspartic acid residues, as well as how these modified structures bind calcium and influence the overall structure of the COMP molecule.
Short trinucleotide repeat mutations
One other case of pathological short trinucleotide repeat expansion has been described: expansion of a (GCG) 6 repeat in the PABP2 gene, within a 10 codon sequence for a polyalanine tract, in patients with oculopharyngeal muscular dystrophy (28) . In this disease, the common (GCG) 6 wild-type sequence was expanded to pathological (GCG) [7] [8] [9] [10] [11] [12] [13] alleles. Our data show that a trinucleotide repeat as short as five can be subject to pathological mutations, and that expansion by a single codon can cause disease. Expansion mutations involving very short tandem repeats are thus distinct from the classical unstable triplet repeat mutations described for the neurodegenerative diseases (reviewed in ref. 29) . As additional examples are identified, these may be viewed as a new class of trinucleotide repeat mutations.
Expansions of three trinucleotide sequences (together with their permutations and complements) have been identified in heritable human phenotypes: CAG, CGG and GAA. The COMP mutations demonstrate that an altered GAC repeat can also produce a disease phenotype. Because GAC repeats are rare in the genome (30), they were not previously associated with human disease.
Mechanism of mutation
With reference to the common PSACH mutation, we have suggested that slippage during replication (rather than recombination) is the most likely mutational mechanism for expansion (10, 12) . A similar explanation has been suggested for the mechanisms by which the PABP2 mutations in oculopharyngeal muscular dystrophy occur (28) , and for other mutations involving short direct repeat sequences (31) . These mutations appear to be meiotically stable, compatible with the stable inheritance of PSACH. In addition, we have not observed altered GAC repeat size, which would imply mitotic instability, in amplified genomic DNA fragments containing the repeat element in either control or patient samples.
Trinucleotide expansion mutations that occur by slippage at replication can be contrasted with the meiotically stable trinucleotide repeat mutations described in the HOXD13 gene in synpolydactyly (32) and in the CBFA1 gene in cleidocranial dysplasia (33) . In these disorders, the diseases are caused by expansion of a polyalanine tract from 15 to 22-25 residues and from 17 to 27 residues, respectively. The expansions differ from those identified in COMP and PABP2 in that they arise from imperfect trinucleotide repeats, and are hypothesized to result from misalignment and unequal crossing over (34) rather than from slippage.
Both the size and the sequence of trinucleotide repeats may affect the types of mutations that can occur and their stability. Long repeats, including the CNG repeats that dramatically expand to yield meiotically and/or mitotically unstable alleles, are thought to be unstable because they form hairpins or other unusual secondary structures (35, 36 and references therein) that cause the polymerase to pause, detach and slip during replication (37) . Even very short CTG/CAG repeats such as (CTG) 4 confer increased flexibility to DNA. A propensity to torsion or bending could destabilize interactions with proteins during replication and lead to genetic instability (38) . Short GAC repeats, such as those in COMP, would not be predicted to assume such genetically unstable structures (30, 35) . Therefore, mutations that alter the length of such repeats may simply result from a baseline replication error frequency engendered by any short tandem repeat sequence, or the sequences might form subtly altered structures that are predisposed to mutations of this type. Since deletion within the COMP repeat unit is observed in about one-third of PSACH patients, but expansion mutations are observed infrequently, it appears that this mutational mechanism favors the generation of deletions.
Cellular pathology of COMP mutations
Studies of tendon and ligament are relevant to the joint laxity that is a common feature of PSACH and presumably all patients with structural mutations in the COMP gene. Tendon and ligament cells are known to synthesize COMP under physiological conditions (1,3-6 ), but no data were available previously regarding the ultrastructure of these cells in patient tissue. We show that both tendon cells and chondrocytes from PSACH and MED patients with COMP mutations contain RER inclusions. In chondrocytes, the material retained in the PSACH inclusions is presumed to be structurally abnormal COMP, possibly in combination with other extracellular matrix proteins (5, 6, 19, 20) , suggesting that COMP interacts with other matrix molecules in vivo. In tendon, abnormalities in COMP may lead to joint laxity by altering analogous interactions with proteins of the tendon extracellular matrix, resulting in reduced tensile strength in the tissue.
Immunohistochemistry experiments in one PSACH patient had shown that COMP was present mostly inside the chondrocytes, while in tendon COMP was detectable in the extracellular matrix (5). This suggested that tendon cells might process abnormal COMP in a manner different from that in cartilage (5) . The electron microscopy data presented here demonstrate that patients with COMP mutations have RER inclusions in tendon cells in vivo. Cultured tendon cells appear to mimic the cellular phenotype and accumulate material in the RER, while control tendon cells do not (39, 40 and this study). Taken together, these results demonstrate at the ultrastructural level, both in vitro and in vivo, that chondrocytes and tendon cells synthesize and secrete COMP in a similar manner. Our data thus suggest that this aspect of the tissue-specific pathology of the COMP disorders occurs by a similar mechanism in cartilage and tendon.
MATERIALS AND METHODS
Patients
Cell cultures were derived from control and patient tissues referred to the International Skeletal Dysplasia Registry at the Cedars-Sinai Research Institute.
Based on a skeletal survey conducted following a motor vehicle accident, a diagnosis of an unclassified form of MED was established at 13 years of age for the proband in family R95-204 (III-1 in Fig. 1 ). At that time, she was noted to have short stature and abnormalities confined to the epiphyses of the long bones. Radiographs taken at 31 years of age revealed dysplastic changes in the epiphyseal regions of the long bones, but the spine and hands were normal. Her affected mother (II-2) had a history of childhood joint pain, in particular in the hips, and underwent surgery to replace the left and right hips at 35 and 37 years of age, respectively. The height of the proband was 153 cm (5th percentile), and her affected mother was 160 cm. By comparison, two unaffected females in the family (III-4 and III-5) were 168 and 173 cm in height, respectively. The affected brother of the proband, III-6, was more severely affected and underwent bilateral osteotomies at 16 years of age for genu varum. The proband underwent hip replacement surgery at age 34, at which time cartilage and tendon from the femoral head were obtained. Electron microscopy of her cartilage revealed inclusions containing a granular material (6) .
A diagnosis of typical PSACH was established at 3 years of age for patient R85-160. Her parents were unaffected and she had an unaffected older sibling. She presented with rhizomelic shortening of her upper and lower extremities, marked joint laxity at the hands, knees and ankles, a slightly decreased range of motion at the elbows, and a height well below the 5th percentile. She had a waddling gait, experienced marked joint pain throughout childhood, and underwent numerous osteotomies for both genu varum and genu valgum deformities. Radiographs demonstrated epiphyseal and metaphyseal abnormalities at all of the long bones. The hands showed delayed epiphyseal ossification and the carpal bones exhibited an etched appearance. The spine showed anterior beaking of the vertebral bodies on lateral projection, typical of patients with PSACH. Iliac crest cartilage and knee tendon tissue were obtained incidental to osteotomies performed at ages 11 and 16, respectively. Electron microscopy of her cartilage (6,24 and this study) revealed the presence of the lamellar RER inclusions observed in most cases of PSACH (18, 19) .
RT-PCR
Total RNA was extracted with Trizol (Gibco BRL) from ∼10 6 cultured chondrocytes grown in monolayer. Reverse transcription was performed with a COMP-specific primer complementary to a sequence located in the 3′-untranslated region of the gene (5′-TTTGTCCTCTCTGAGCCCTTC-3′) with the Superscript pre-amplification system (Gibco BRL). The entire calmodulinlike region was amplified by PCR (94_C 1 min; 62_C 1 min; 72_C 1 min; cycles) with oligonucleotides 5′-GACTGATATCG-GTCGCGACACTGACCTAGAC-3′ [containing a sequence homologous to nucleotides 824-844 (numbering according to ref.
21)] and 5′-GACTAAGCTTCTAAGCGTTCTCCGGACACA-CGT-3′ (containing a sequence complementary to nucleotides 1578-1597). These oligonucleotides contain non-COMP sequences at their 5′ ends, incorporated for other purposes. The PCR products were ligated into a TA-vector (plasmid pCR-II; Invitrogen). Sequence was determined for 10 clones from each patient (Thermosequenase kit; Amersham) with the oligonucleotide 5′-CCCGGATCAGGCGGATGTGGA-3′ (COMP nucleotides 1270-1290) as the sequencing primer. For MED patient R95-204, six clones contained the wild-type sequence and four contained the mutant sequence. For PSACH patient R85-160, five normal and five mutant clones were found.
Genomic amplification
An intron 12 forward primer (5′-GGGTAGCCTTTGACAAAA-CG-3′) was labeled with γ-33 P and used to amplify genomic DNA with an exon 13 reverse primer (5′-GTTAGGCACCAGGCGG-CAG-3′) by PCR (94_C 1 min; 65_C 1 min; 72_C 1 min; 32 cycles). For control genomic DNA, the reaction yielded a single band of 184 bp. PCR products were separated on 6% denaturing polyacrylamide gels. Heteroduplex analysis was performed with the same primers, and PCR products were separated on non-denaturing 6% denaturing polyacrylamide gels.
Electron microscopy
Electron microscopy of cartilage and tendon was performed as described (41) .
